This site is intended for health professionals only

Home
>
Editor’s pick

Editor’s pick

Enoxaparin trumps UFH across board

Enoxaparin trumps UFH across board

Gemtuzumab-platelet combination fatality link

Gemtuzumab-platelet combination fatality link

Safety report covers 60,000 incidents

Safety report covers 60,000 incidents

Merck attacks Financial Times report

Merck attacks Financial Times report

Ramipril-candesartan combination offers gains

Ramipril-candesartan combination offers gains

European authorisation for schizophrenia drug

European authorisation for schizophrenia drug

Sanofi pulls US rimonabant application

Sanofi pulls US rimonabant application

EU new-drug cooperation urged

EU new-drug cooperation urged

Genmab regains lymphoma drug rights

Genmab regains lymphoma drug rights

Belgian firm’s CFO to quit

Belgian firm’s CFO to quit

Lapatinib: an oral dual ErbB1 and ErbB2 inhibitor for the treatment of breast cancer

Lapatinib: an oral dual ErbB1 and ErbB2 inhibitor for the treatment of breast cancer

Computerised drug alerts: progress, but a long way to go

Computerised drug alerts: progress, but a long way to go

« Previous 1 … 255 256 257 258 259 … 302 Next »

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x